From the clinic floor to clinical trial software.

I trained as a physiotherapist, studied how hospitals run, and now build the software research teams use to run clinical trials. Every product decision I make still starts the way a patient assessment does.

Let's talk How I work

Now

Updated September 2026,
from Snohomish, WA

Leading product for the next generation of the Talosix EDC — study setup, visit schedules, subject management, ePRO, safety, database lock and reporting.
Designing AI-assisted study setup: upload a protocol, get a suggested study configuration a data manager can review and approve.
Fresh back from SCDM 2026 in Raleigh, thinking about where AI truly reduces data-cleaning burden versus just moving the work upstream.

The trail so far

I started in healthcare as a clinician, not a coder.

Four waypoints, and what I carried forward from each.

2006
KEM Hospital, Mumbai
Physiotherapy
Bachelor of Physiotherapy, Seth G.S. Medical College & KEM Hospital
“Assess before you treat. Every plan starts with the person in front of you.”
2016
TISS, Mumbai
Hospital administration
Master of Hospital Administration, Tata Institute of Social Sciences
“Care is a system. Workflows, staffing and data decide what a clinician can actually do.”
2018
Optum (UnitedHealth Group)
Product Owner
Provider solutions and CMS Risk Adjustment
“At scale, data quality is patient care. Millions of records, zero room for sloppiness.”
2019
Talosix, Seattle
Product Owner → Technical Product Manager
Clinical trial platform, from study management to the next-generation EDC
“Regulated doesn't have to mean painful. Compliance and delight can ship together.”

Work

What I've helped build

Seven years at Talosix, an AI-enabled clinical research platform used by sponsors, CROs and providers. Before that, CMS Risk Adjustment products at Optum.

Live at Talosix

Electronic Data Capture
Faster data entry for sites: from 50 minutes to under 10 per instrument.
Patient Screening
AI-assisted identification of eligible trial participants.
Patient Engagement
ePRO and surveys that patients complete from home.
Study management & reporting
Analytics dashboards and reporting for sponsors, CROs and sites.

Building now

Next-generation Talosix EDC
Rebuilding study setup through database lock around AI assistance, with a human in the lead.
AI-assisted study startup
Getting from protocol to a live study faster, with reviewable AI suggestions instead of blank forms.

Exploring, after SCDM 2026

Cutting data-cleaning burden, not moving it
Where AI actually removes work for data managers versus shifting it upstream.
Risk-proportionate design
Not every data point deserves equal scrutiny. Designing checks around what matters.
Fit-for-purpose data collection
Collect what the protocol needs, not everything that's possible.
Continuous evidence & monitoring
Governance designed in from the start, not assembled after the fact.

Fluent in 21 CFR Part 11, ICH GCP, HIPAA, CDISC, OMOP and FHIR. New to clinical trials? Start with the plain-English glossary →

How I work

Clinical instincts, product decisions

All principles →

Identify the right problem first

Everything downstream depends on framing the problem correctly. I spend disproportionate time here.

Fit for purpose, not comprehensive

Less is more. The best clinical software asks for exactly what the protocol needs.

Risk proportionality

Not every risk deserves equal weight, and treating them as if they do is its own kind of failure.

All principles →

Writing

Field notes

All writing →

Clinical data management

What SCDM 2026 taught me about purpose

Lindsey Wahlstrom took the stage at SCDM 2026 to share an incredibly moving, heartbreaking story of her child's battle with a rare disease. Hearing her perspective—and her family's journey through clinical trials—reframe

Sep 17, 2026 FDA

The FDA and real-time clinical trials

The FDA recently announced real-time clinical trials. AstraZeneca and Amgen are already piloting trials that report endpoints and safety signals to the agency as they happen. Chief AI Officer Jeremy Walsh estimated this

May 15, 2026 Product management